I too am interested in this documentation. I'm aware of concerns going back over more than a decade, when somebody stopped me in the grocery store to warn me about the BPA in plastic liners in a can of crushed tomatoes. Since then I've kept an eye on the situation. This has turned up plenty of concerns, and a lot of "folk" documentation of harm.
However, I haven't seen relevant scientific documentation that would indicate that the FDA should act. If there is some documentation, there should be a lawsuit to force the FDA to act. There are plenty of interested watchdog groups that would fund something like that.
If you can provide that, I'm getting on the phone today to start lobbying.
Documented harm? Come on, stop making things up. There are hints at correlations between BPA exposure and adverse health effects. There are animal studies with extremely high doses.
But there is no direct evidence of adverse health effects on any humans caused by BPA.
I don't see why you're getting downvoted. He made a claim without evidence. I've also been unable to locate studies documenting an observed risk to humans.
I took the last part of his statement and entered it into Google, "adverse health effects on any humans caused by BPA.". The results are interesting. Search the results page for ".gov" sites.
Yes, and the reliable sources contradict what he's said. Which makes me think that solipsism was not out of line to call him out for making stuff up.
For example from WebMD:
>The federal government is now funding new research into BPA risks. We don't know the results of these studies yet. Recommendations about BPA could change in the next few years.
>For now, there are no restrictions on the use of BPA in products. The Food and Drug Administration does recommend taking "reasonable steps" to reduce human exposure to BPA in the food supply. The FDA has also expressed support for manufacturers who have stopped using BPA in products for babies and for companies working to develop alternatives to the BPA in canned foods.
>There are data showing that exposure to BPA,
as well as other endocrine disrupting chemicals with estrogenic activity, may have e ects on obesity and diabetes. These data, while preliminary and only in animals, indicate the potential for endocrine disrupting agents to have e ects on other endocrine systems not yet fully examined.
So in summary it seems that the FDA is acting appropriately, not out of the ordinary. They are studying the issue, but there's not yet documented harm.
